Equideum Health has partnered with Nokia Bell Labs to research cognitive augmentation using blockchain combined with AI and edge devices such as earpieces, smartwatches, and home devices.
The joint applied research agenda would be on how they would approach the ethics, identity, cybersecurity, and compliance challenges concerning edge data on all devices, including earables and other remote telemetry devices currently being used, according to Heather Flannery, CEO of Equideum Health.
Nokia has created an earable — a wearable ear gadget with a microphone and speaker – that can utilize on-device machine learning to assist individuals in understanding and responding to the environment around them.
This type of device receives a wide range of very private data, which raises several ethical concerns.
Flannery noted that the concern is whether a guardian or legal representative might opt-in to share data that the patient would not agree to if they were capable of making the decision themself. That’s especially where financial incentives are involved.
She added that they bring improvements in transparency, audio, privacy, and cybersecurity. Improvements over baseline versus further infringement or compromise on the agency and empowerment of the individual.
There have been numerous reports in the media of people in care being mistreated or ignored. Most care facilities contain sensors and monitors, which are also IoT devices,
in addition to wearables. The Equideum Foundation's director, Dr. Pierre Vigilance, pointed out that better data management could assist individuals to get better care.


SpaceX IPO Demand Surges Past $250 Billion Ahead of Historic Market Debut
US Dollar Heads for Weekly Loss as Iran Peace Deal Hopes Boost Risk Appetite
Eli Lilly and Insilico Medicine Forge $2.75 Billion AI-Driven Drug Discovery Deal
Apple Unveils Enhanced Apple Intelligence and Next-Generation Siri at WWDC 2026
Trump Signals Possible U.S.-Iran Peace Deal as Hormuz Reopening Nears
oOh!media Takeover Battle Intensifies as Bain Capital Joins Competing Bids
TrumpRx Expands Discount Drug Access With 600 Generic Medications
Switch Eyes Multi-Billion-Dollar Funding Round at $50 Billion Valuation Ahead of Potential IPO
Dollar Stabilizes as Markets Weigh Middle East Ceasefire Prospects and Central Bank Policy Outlook
FDA Biologics Chief Vinay Prasad to Leave Agency in April Amid Policy Disputes
Oracle Stock Falls Despite Earnings Beat as Company Plans $40 Billion Financing for FY2027
US Plans Kenya Ebola Quarantine Facility Amid Congo Outbreak
Oil Prices Fall as Trump Signals Iran Deal, Reducing Supply Risk Concerns
Meta Partners With Reliance to Launch First AI-Powered Data Center in India
Hanmi Semicon Shares Surge After $33 Million SpaceX Investment
Adobe Beats Q2 2026 Estimates, Raises Full-Year Outlook as AI Revenue Surges Despite Stock Drop 



